At the news
? MIXEDIMPACT 5/10 8-K filed Jun 30, 2026 at 16:19 ET
Oramed Pharmaceuticals extended payment obligations from Scilex Holding Company, covering approximately $29.5M Tranche A Note and $6.7M Tranche B Note. Scilex agreed to pay $0.5M immediately and the remaining balance by September 30, 2026, with stock settlement if default occurs. The bylaw amendments are routine governance changes.
- Extension agreement with Scilex for outstanding notes: Tranche A ~$29.5M, Tranche B ~$6.7M as of June 30, 2026
- Scilex paid $0.5M on June 25, 2026; further $5M due by July 31, 2026; full balance by September 30, 2026
- If Scilex defaults, first $1.5M retained as fee and remaining obligations may be settled with Scilex common stock
- Bylaws amended to simplify record date procedures for stockholder action by written consent and tighten consent delivery timeline
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access